Biocon Pledges To Cut Insulin Prices

India’s Biocon has pledged to cut the price of insulin to 10 cents per day in low- and middle-income nations

India’s Biocon has promised to cut by 50% the cost of recombinant human insulin to 10 cents a day in low- and middle-income nations to help make the life-saving medication “universally accessible.”

Dime
Biocon says it will cut the daily cost of insulin to 10 cents • Source: Shutterstock

Biocon’s founder and managing director Kiran Mazumdar-Shaw has said the company is ready to slash the cost of recombinant human insulin it sells in low- and middle-income countries by 50% – and possibly more – to 10 cents a day.

Speaking at a UNAIDS Health Innovation function in New York, the self-made billionaire who is one of India’s best-known philanthropists...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Drug Pricing

More from Policy & Regulation

  • For Generics, A Victory Lap – And A Warning – On Drug Shortages

    Avoiding disaster at the beginning of the pandemic and offering a pro-active supply chain blueprint should position the generics industry well for an onshoring debate in Congress, but a look back at March 2020 is a reminder that even small policy shifts can have a big impact.

  • GB-Policy&Regulation-Free: Article with different widgets

    Emerging CRISPR innovations, shifting regulatory landscapes, and rising partnerships are accelerating a paradigm shift in biotech pipelines

  • Overseas API Manufacturing Identified As Key Vulnerability In US Supply Chain

    After US President Joe Biden launched a review of the country’s API supply chain, the task force has reported back with key vulnerabilities that contribute to drug shortages and supply risks during a global public health emergency. According to the report, the lack of geographic diversity and dependence on foreign nations and anti-competitive actions by foreign nations are key areas of concern.